Sword Health

The study, sponsored by digital musculoskeletal-care company SWORD Health, also found improvements in secondary measures like surgery intent and painkiller use.

SWORD raised $163 million in Series D funding, which allowed for a secondary round where it scooped up another $26 million.

This week's top stories include Cerner mandating that all U.S. employees be vaccinated by Dec. 8, digital musculoskeletal care company SWORD Health acquiring Vigilant Technologies, and air ambulance charges rising substantially in four years.

Vigilant Technologies makes a shirt-collar wearable that uses haptic feedback to improve posture and reduce workplace injury.

This new funding brings the company's total funding pot to $135 million. 

The round was led by Todd Cozzens and had participation from existing investors Khosla Ventures, Founders Fund, Green Innovations, Vesalius Biocapital and Faber.   

The round was led by Khosla Ventures with participation from Founders Fund, Green Innovations, Lachy Groom, Vesalius Biocapital and Faber Ventures. 

Also: Sword Health appoints new clinical advisory board; AbleTo brings in new medical director. 

Building on research published last month, the company plans to use the funding to secure additional clinical validation.

Two papers from Sword Health's researchers suggest the company's Digital Therapist platform is well received and more effective than standard rehabilitation.